After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Joseph Romanelli, president, Human Health International, and Dr. Marjorie Green, senior vice president and ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Oct. 28, 2024 — As cannabis is legalized and is more accessible in various forms across the country, there is increasing concern among health care providers about potential impact on children.

South Africa’s ICJ legal team says intent ‘clear’ in Israel’s Gaza genocide Monday is the ICJ’s deadline for South Africa to prove, on paper, that Israel is guilty of genocide in Gaza.

But researchers found the decline was smaller in places with less hospital competition. Public health leaders warned of an incoming fiscal cliff during the pandemic, when the federal government ...

Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...

This study provides a comprehensive look at the different types of antibody drugs, including human, humanized ... This means ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Merck & Company ( (MRK) ) has released its Q3 earnings. Here is a breakdown of the information Merck & Company presented to its ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.